Mitochondrial perturbance and execution of apoptosis in platelet mitochondria of patients with amyotrophic lateral sclerosis

International Journal of Neuroscience

Volumn 121, Issue 3, 2011, Pages 149-158

  Shrivastava, Mohita ^a   Vivekanandhan, S ^a   Pati, Uttam ^a,b   Behari, Madhuri ^a,b   Das, Taposh K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

ALS; apoptosis; confocal microscopy; flow cytometry; mitochondrial perturbance; platelets

Indexed keywords

DYE; LIPOCORTIN 5; MONOMER; PHOSPHATIDYLSERINE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MOTONEURON; PATHOGENESIS; THROMBOCYTE;

AMYOTROPHIC LATERAL SCLEROSIS; ANNEXIN A5; APOPTOSIS; BENZIMIDAZOLES; BLOOD PLATELETS; CARBOCYANINES; CASE-CONTROL STUDIES; FLUORESCENT DYES; HUMANS; MEMBRANE LIPIDS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, CONFOCAL; MIDDLE AGED; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION; PHOSPHATIDYLSERINES;

EID: 79952151628     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2010.537416     Document Type: Article

References (52)

1. Barber, S. C., Mead, R. J., & Shaw, P. J. (2006). Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochimica et Biophysica Acta, 1762(11-12), 1051-1067. (Pubitemid 44750575)
2. Beal, M. F. (1996). Mitochondria, free radicals, and neurodegeneration. Current Opinion Neurobiology, 6(5), 661-666.
3. Bos, I. W., Hoogland, G., Meine Jansen, C. F., Willigen, G., Spierenburg, H. A., Van Den Berg, L. H., et al. (2006). Increased glutamine synthetase but normal EAAT2 expression in platelets of ALS patients. Neurochemistry International, 48(4), 306-311.
4. Brooks, B. R. (1994). El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. Journal of Neurological Sciences, 124, 96-107.
5. Brustovetsky, N., Brustovetsky, T., Jemmerson, R., & Dubinsky, J. M. (2002). Calcium induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane. Journal of Neurochemistry, 80(2), 207-218. (Pubitemid 34809366)
6. Buckman, J. F., Hernández, H., Kress, G. J., Votyakova, T. V., Pal, S., & Reynolds, I. J. (2001). Mitotracker labeling in primary neuronal and astrocytic cultures: Influence of mitochondrial membrane potential and oxidants. Journal of Neuroscience Methods, 104(2), 165-176. (Pubitemid 32042519)
7. Carole Ferraro-Peyret, Quemeneur, L., Flacher, M., Revillard, J. P., & Genestier, L. (2002). Caspase-independent phosphatidylserine exposure during apoptosis of primary T lymphocytes. Journal of Immunology, 169, 4805-4810. (Pubitemid 35217143)
8. Castedo, M., Hirsch, T., Susin, S. A., Zamzami, N., Marchetti, P., Macho, A., et al. (1996). Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. Journal of Immunology, 157(2), 512-521. (Pubitemid 26231350)
9. Chaudhuri, K. R., Crump, S., al-Sarraj, S., Anderson, V., Cavanagh, J., & Leigh, P. N. (1995). The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: A clinicopathological study. Journal of Neurological Sciences, 129, 11-12.
10. Cleveland, D. W., & Rothstein, J. D. (2001). From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nature Reviews Neuroscience, 2(11), 806-819. (Pubitemid 33674062)
11. Cossarizza, A., Ceccarelli, D., & Masini, A. (1996). Functional heterogeneity of isolated mitochondrial population revealed by cytofluorimetric analysis at the single organelle level. Experimental Cell Research, 222, 84-94. (Pubitemid 26046576)
12. Cossarizza, A. & Salvioli, S. (2001a). Flow cytometric analysis of mitochondrial membrane potential using JC-1. Current Protocols in Cytometry. Chapter 9, Unit 9.14.
13. Cossarizza, A., & Salvioli, S. (2001b). Analysis of mitochondria during cell death. Methods Cell Biol., 63, 467-486. (Pubitemid 33797817)
14. Curti, D., Malaspina, A., Facchetti, G., Camana, C., Mazzini, L., Tosca, P., et al. (1996). Amyotrophic lateral sclerosis: Oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology, 47, 1060-1064.
15. Dupuis, L., Gonzalez de Aguilar, J. L., Oudart, H., de Tapia, M., Barbeito, L., & Loeffler, J. P. (2004). Mitochondria in amyotrophic lateral sclerosis: A trigger and a target. Neurodegenerative Diseases, 1(6), 245-254.
16. Ferrarese, C., Sala, G., Riva, R., Begni, B., Zoia, C., Tremolizzo, L., et al.; Italian ALS Study Group. (2001). Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology, 56(2), 270-272.
17. Ferrick, D. A., Neilson, A., & Beeson, C. (2008). Advances in measuring cellular bioenergetics using extracellular flux. Drug Discovery Today, 13(5-6), 268-274.
18. Fiskum, G. (2000). Mitochondrial participation in ischemic and traumatic neural cell death. Journal of Neurotrauma, 17(10), 843-855.
19. Friedlander, R. M. (2003). Apoptosis and caspases in neurodegenerative diseases. The New England Journal of Medicine, 348(14), 1365-1375.
20. Garcia-Ruiz, C., Colell, A., Paris, R., & Fernandez-Checa, J. C. (2000). Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation. FASEB Journal, 14(7), 847-858. (Pubitemid 30241661)
21. Hengartner, M. O. (2000). The biochemistry of apoptosis. Nature, 407, 770-776.
22. Jayaraman, S. (2005). Flow cytometric determination of mitochondrial membrane potential changes during apoptosis of T lymphocytic and pancreatic beta cell lines: Comparison of etramethyl-rhodamineethylester (TMRE), chloromethyl-X-rosamine (H2- CMX-Ros) and MitoTracker Red 580 (MTR580). Journal of Immunological Methods, 306(1-2), 68-79.
23. Kahn, E., Lizard, G., Monier, S., Bessède, G., Frouin, F., Gambert, P., et al. (2002). Flow cytometry and factor analysis evaluation of confocal image sequences of morphologic and functional changes occurring at the mitochondrial level during 7-ketocholesterol-induced cell death. Analytical and Quantitative Cytology and Histology, 24(6), 355-362. (Pubitemid 35453464)
24. Khan, S. M., Cassarino, D. S., Abramova, N. N., Keeney, P. M., Borland, M. K., Trimmer, P. A., et al. (2000). Alzheimer's disease cybrids replicate betaamyloid abnormalities through cell death pathways. Annals of Neurology, 48, 148-155. (Pubitemid 30617032)
25. Kiktenko, A. I., Zlobina, G. P., Brusov, O. S., & Zakharova, M. N. (2005). Structure of peripheral blood platelets surface in patients with amyotrophic lateral sclerosis and multiple sclerosis. Zh Nevrol Psikhiatr Im S S Korsakova, 105(3), 40-42. (Pubitemid 44077232)
26. Kile, B. T. (2009). The role of the intrinsic apoptotic pathway in platelet life and death. Journal of Thrombosis and Haemostasis, 7(1), 214-217.
27. Koopman, C., Reutelingsperger, C. P. M., Kuijten, G. A. M., Keehnen, R. M. J., Pals, S. T., & van Oers, M. H. J. (1994). Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood, 84, 1415-1420. (Pubitemid 24273007)
28. Kushnareva, Y. E., Polster, B. M., Sokolove, P. M., Kinnally, K. W., & Fiskum, G. (2001). Mitochondrial precursor signal peptide induces a unique permeability transition and release of cytochrome c from liver and brain mitochondria. Archives of Biochemistry and Biophysics, 386(2), 251-260. (Pubitemid 32989315)
29. Leytin, V., Allen, D. J., Mutlu, A., Gyulkhandanyan, A. V., Mykhaylov, S., & Freedman, J. (2009). Mitochondrial control of platelet apoptosis: effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition pore. Laboratory Investigations, 89(4), 374-384.
30. Leytin, V., Allen, D. J., Mutlu, A., Mykhaylov, S., Lyubimov, E., & Freedman, J. (2008). Platelet activation and apoptosis are different phenomena: evidence from the sequential dynamics and the magnitude of responses during platelet storage. British Journal of Haematology, 142(3), 494-497. (Pubitemid 351962184)
31. Leytin, V., Mody, M., Semple, J. W., Garvey, B., & Freedman, J. (2000). Flow cytometric parameters for characterizing platelet activation by measuring P-selectin (CD62) expression: theoretical consideration and evaluation in thrombin-treated platelet populations. Biochemical and Biophysical Research Communications, 269(1), 85-90. (Pubitemid 30440259)
32. Menzies, F. M., Ince, P. G., & Shaw, P. J. (2002). Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochemistry International, 40(6), 543-551. (Pubitemid 34159155)
33. Merlo Pich, M., Bovina, C., Formiggini, G., Cometti, G. G., Ghelli, A., Parenti, C. G., et al. (1996). Inhibitor sensitivity of respiratory complex I in human platelets, a possible biomarker of ageing. FEBS Letters, 380, 176-178. (Pubitemid 26058753)
34. Nakano, Y., Hirayama, K., & Terao, K. (1987). Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis. Archives of Neurology, 44(1), 103-106. (Pubitemid 17087619)
35. Perrotta, P. L., Perrotta, C. L., & Snyder, E. L. (2003). Apoptotic activity in stored human platelets. Transfusion, 43(4), 526-535. (Pubitemid 36428337)
36. Picker, S. M., Schneider, V., Oustianskaia, L., & Gathof, B. S. (2009). Cell viability during platelet storage in correlation to cellular-metabolism after different pathogen reduction technologies. Transfusion, 49(11), 2311-2318.
37. Pignatelli, P., Pulcinelli, F. M., Lenti, L., Gazzaniga, P. P., & Violi, F. (1998). Hydrogen peroxide is involved in collagen-induced platelet activation. Blood, 91(2), 484-490. (Pubitemid 28053370)
38. Polster, B. M., Kinnally, K. W., & Fiskum, G. (2001). BH3 death domain peptide induces cell type-selective mitochondrial outer membrane permeability. Journal of Biological Chemistry, 276(41), 37887-37894.
39. Rosado, J. A., Redondo, P. C., Salido, G. M., Gómez-Arteta, E., Sage, S. O., & Pariente, J. A. (2004). Hydrogen peroxide generation induces pp60src activation in human platelets: Evidence for the involvement of this pathway in store-mediated calcium entry. Journal of Biological Chemistry, 279(3), 1665-1675. (Pubitemid 38084433)
40. 6(3) or rhodamine 123, is a reliable fluorescent probe to assess DY in intact cells. Implications for studies on mitochondrial functionality during apoptosis. FEBS Letters, 411, 77-82,
41. Seghatchian, J., & Krailadsiri, P. (2001). Platelet storage lesion and apoptosis: are they related? Transfusion and Apheresis Science, 24(1), 103-105.
42. Seno, T., Inoue, N., Gao, D., Okuda, M., Sumi, Y., Matsui, K., et al. (2001). Involvement of NADH/NADPH oxidase in human platelet ROS production. Thrombosis Research, 103(5), 399-409. (Pubitemid 32831474)
43. Swerdlow, R. H. (2007). Mitochondria in Cybrids Containing mtDNA from persons with mitochondriopathies. Journal of Neuroscience Research, 85, 3416-3428.
44. Swerdlow, R. H., Parks, J. K., Cassarino, D. S., Trimmer, P. A., Miller, S. W., Maguire, D. J., et al. (1998).Mitochondria in sporadic amyotrophic lateral sclerosis. Experimental Neurology, 153, 135-142. (Pubitemid 28452305)
45. Swerdlow, R. H., Parks, J. K., Pattee, G., & Parker, W. D. Jr. (2000). Role of mitochondria in amyotrophic lateral sclerosis. Amyotroph Lateral Sclerosis and Other Motor Neuron Disorders, 1, 185-190.
46. Trimmer, P. A., Keeney, P. M., Borland, M. K., Simon, F. A., Almeida, J., Swerdlow, R. H., et al. (2004). Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture. Neurobiology of Disease, 15, 29-39. (Pubitemid 38134378)
47. Trimmer, P. A., Swerdlow, R. H., Parks, J. K., Keeney, P., Bennett, J. P. Jr., Miller, S. W., et al. (2000). Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Experimental Neurology, 162, 37-50. (Pubitemid 30170099)
48. Verhoeven, A. J., Verhaar, R., Gouwerok, E. G., & de Korte, D. (2005). The mitochondrial membrane potential in human platelets: A sensitive parameter for platelet quality. Transfusion, 45(1), 82-89.
49. Vielhaber, S., Kunz, D., Winkler, K., Weidemann, F. R., Kirches, E., Feistner, H., et al. (2000). Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain, 123, 1339-1348. (Pubitemid 30420935)
50. Wiedemann, F. R., Winkler, K., Kuznetsov, A. V., Bartels, C., Vielhaber, S., Feistner, H., et al. (1998). Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. Journal of Neurological Science, 156, 65-72. (Pubitemid 28141041)
51. Xu, J., Shi, C., Li, Q., Wu, J., Forster, E. L., & Yew, D. T. (2007). Mitochondrial dysfunction in platelets and hippocampi of senescence-accelerated mice. Journal of Bioenergetics and Biomembranes, 39(2), 195-202. (Pubitemid 46870549)
52. Yuan, J., & Yankner, B. A. (2000). Apoptosis in the nervous system. Nature, 407, 802-809.